Dysregulated Expression Patterns of Circular RNAs in Cancer: Uncovering Molecular Mechanisms and Biomarker Potential

Nicole R DeSouza1, Kate J Nielsen1, Tara Jarboe1

  • 1Department of Pathology, Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA.

Biomolecules
|April 27, 2024
PubMed

Insights

Circular RNAs (circRNAs) are novel non-coding RNA molecules. Their dysregulation drives cancer, offering potential as diagnostic biomarkers for early detection and personalized medicine.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Circular RNAs (circRNAs) are non-coding RNA molecules formed by back-splicing.
  • They possess stable structures and regulatory functions.
  • Dysregulated circRNA expression is implicated in cancer development.

Purpose of the Study:

  • To review the novel roles of circRNAs in cancer.
  • To highlight their potential as diagnostic and prognostic biomarkers.
  • To explore their application in personalized medicine.

Main Methods:

  • Literature review of studies on circRNA biogenesis and function.
  • Analysis of circRNA involvement in epigenetic modifications and cancer pathways.
  • Evaluation of circRNA expression patterns for biomarker discovery.

Main Results:

  • CircRNAs exhibit dynamic regulatory capabilities via RNA and protein-binding domains.
  • Their dysregulation contributes to carcinogenic and tumorigenic processes.
  • Novel molecular and cellular patterns in cancer cells are identified through circRNA studies.

Conclusions:

  • CircRNAs are emerging as significant players in cancer biology.
  • Reliable circRNA expression patterns can facilitate early disease detection.
  • CircRNAs hold promise as genome-specific biomarkers for personalized cancer medicine.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.0K